Sign up to save your podcasts
Or
Share Considerations for Use of Two Newly Approved Drugs
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Considerations for Use of Two Newly Approved Drugs
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, discuss factors to consider when bringing perfluorohexyloctane ophthalmic solution (Miebo, Bausch + Lomb) and lotilaner ophthalmic solution 0.25% (Xdemvy, Tarsus Pharmaceuticals) into your clinical practice.
View all episodes
By Modern Optometry
5
1515 ratings
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, discuss factors to consider when bringing perfluorohexyloctane ophthalmic solution (Miebo, Bausch + Lomb) and lotilaner ophthalmic solution 0.25% (Xdemvy, Tarsus Pharmaceuticals) into your clinical practice.
More shows like To the Point
View all
Power Hour Optometry
78 Listeners
Defocus Media Eyecare and Optometry Podcast Network
57 Listeners
The Daily
110,759 Listeners
Try Not To Blink
63 Listeners
20/20 MONEY
80 Listeners
EyeCode Media
101 Listeners
The MOD Pod
5 Listeners
Four Eyes
19 Listeners
Optometric Insights Media
20 Listeners
The Optometry Money Podcast
13 Listeners
The Dr. April Jasper Show
14 Listeners
EYE OWN A BUSINESS
18 Listeners
Mo News
1,832 Listeners
Eye Give a Damn!
17 Listeners
ODs on Education Podcast
11 Listeners